Shi-Bing Liang

443 total citations
28 papers, 274 citations indexed

About

Shi-Bing Liang is a scholar working on Complementary and alternative medicine, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shi-Bing Liang has authored 28 papers receiving a total of 274 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Complementary and alternative medicine, 8 papers in Pharmacology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shi-Bing Liang's work include Pharmacological Effects of Natural Compounds (6 papers), Complementary and Alternative Medicine Studies (5 papers) and Plant-based Medicinal Research (4 papers). Shi-Bing Liang is often cited by papers focused on Pharmacological Effects of Natural Compounds (6 papers), Complementary and Alternative Medicine Studies (5 papers) and Plant-based Medicinal Research (4 papers). Shi-Bing Liang collaborates with scholars based in China, United Kingdom and Norway. Shi-Bing Liang's co-authors include Jianping Liu, Nicola Robinson, Mei Han, Yapeng Zhang, Ruixue Hu, Bing-Jie Chen, Kevin Chen, Yutong Fei, Huijuan Cao and Yingying Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Medicine.

In The Last Decade

Shi-Bing Liang

25 papers receiving 271 citations

Peers

Shi-Bing Liang
Shi-Bing Liang
Citations per year, relative to Shi-Bing Liang Shi-Bing Liang (= 1×) peers Saeid Heidari-Soureshjani

Countries citing papers authored by Shi-Bing Liang

Since Specialization
Citations

This map shows the geographic impact of Shi-Bing Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shi-Bing Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shi-Bing Liang more than expected).

Fields of papers citing papers by Shi-Bing Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shi-Bing Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shi-Bing Liang. The network helps show where Shi-Bing Liang may publish in the future.

Co-authorship network of co-authors of Shi-Bing Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Shi-Bing Liang. A scholar is included among the top collaborators of Shi-Bing Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shi-Bing Liang. Shi-Bing Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Yingying, Yuan Wang, Chen Shen, et al.. (2024). Effect of acupressure on smoking cessation in young smokers with nicotine dependence: A mixed methods study. Integrative Medicine Research. 14(1). 101120–101120.
2.
Zhang, Yingying, Shi-Bing Liang, Yufei Li, et al.. (2024). Acupuncture and related acupoint therapies for smoking cessation: An umbrella review and updated meta-analysis. Tobacco Induced Diseases. 22(April). 1–18. 4 indexed citations
3.
Zhang, Qiong, Xueqing Wu, Chunhui Wang, et al.. (2024). Hongjin Xiaojie Capsule, a Chinese patent medicine, for treating moderate to severe cyclical breast pain: A single-blind randomized controlled trial. Journal of Integrative Medicine. 22(5). 552–560.
4.
Wang, Yiying, et al.. (2023). Bloodletting therapy for primary headache: A systematic review and meta-analysis of randomized controlled trials. European Journal of Integrative Medicine. 64. 102312–102312. 1 indexed citations
5.
Fang, Min, Sijia Zhu, Xiao-Yang Hu, et al.. (2022). Effectiveness and Safety of Chinese Medicine at Shenque (CV 8) for Primary Dysmenorrhea: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chinese Journal of Integrative Medicine. 29(4). 341–352. 5 indexed citations
7.
Liang, Shi-Bing, Huijuan Cao, Jiali Wei, et al.. (2022). Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials. Frontiers in Pharmacology. 13. 904657–904657. 8 indexed citations
8.
Liang, Shi-Bing, Min Fang, Di Lan, et al.. (2021). Therapeutic effects and safety of oral Chinese patent medicine for COVID-19: A rapid systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 60. 102744–102744. 26 indexed citations
9.
Liang, Shi-Bing, et al.. (2021). Compound glycyrrhizin injection for improving liver function in children with acute icteric hepatitis: A systematic review and meta-analysis. Integrative Medicine Research. 11(1). 100772–100772. 9 indexed citations
10.
Zhang, Yingying, Di Lan, Shi-Bing Liang, et al.. (2021). Non-traditional Acupuncture Therapies for Smoking Cessation: A Systematic Review of Randomized Controlled Trials. Research Square. 1 indexed citations
11.
Zhang, Yingying, Shi-Bing Liang, Xiao-Yang Hu, et al.. (2021). Chinese patent herbal medicine (Shufeng Jiedu capsule) for acute upper respiratory tract infections: A systematic review and meta-analysis. Integrative Medicine Research. 10(3). 100726–100726. 10 indexed citations
12.
Liang, Shi-Bing, Yingying Zhang, Chen Shen, et al.. (2021). Chinese Herbal Medicine Used With or Without Conventional Western Therapy for COVID-19: An Evidence Review of Clinical Studies. Frontiers in Pharmacology. 11. 583450–583450. 13 indexed citations
13.
Zhang, Yingying, Di Lan, Shi-Bing Liang, et al.. (2021). Non-traditional acupuncture therapies for smoking cessation: a systematic review of randomized controlled trials. European Journal of Integrative Medicine. 47. 101390–101390. 5 indexed citations
14.
Liang, Shi-Bing, et al.. (2020). Chinese herbal medicine (Rupi Sanjie capsule) for the treatment of breast pain: A systematic review and meta-analysis of randomized clinical trials. Integrative Medicine Research. 10(2). 100491–100491. 2 indexed citations
15.
Liu, Jianping, Shi-Bing Liang, Ning Liang, et al.. (2020). The Potential effects and use of chinese herbal medicine pine pollen (Pinus pollen): A bibliometric analysis of pharmacological and clinical studies. World Journal of Traditional Chinese Medicine. 6(2). 163–163. 18 indexed citations
16.
Liang, Shi-Bing, Huijuan Cao, Xue Bai, et al.. (2020). Pediatric tuina for the treatment of anorexia in children under 14 years: a systematic review and meta-analysis of randomized controlled trials. Complementary Therapies in Medicine. 51. 102411–102411. 14 indexed citations
17.
Zhang, Yapeng, Ruixue Hu, Mei Han, et al.. (2020). Evidence Base of Clinical Studies on Qi Gong: A Bibliometric Analysis. Complementary Therapies in Medicine. 50. 102392–102392. 61 indexed citations
18.
Liang, Ning, et al.. (2019). Evaluation of outcomes reported in randomized controlled trials for herbal remedies for adults with chronic hepatitis C. SHILAP Revista de lepidopterología. 6(2). 115–121. 2 indexed citations
19.
Liu, Xuehan, Trine Stub, Agnete E. Kristoffersen, et al.. (2019). Correction to: Complementary and alternative medicine for treatment of atopic eczema in children under 14 years old: a systematic review and meta-analysis of randomized controlled trials. BMC Complementary and Alternative Medicine. 19(1). 1 indexed citations
20.
Liang, Shi-Bing, et al.. (2019). Clinical effects and safety of Compound Glutamine Entersoluble Capsules for diarrhea-predominant irritable bowel syndrome: A systematic review and meta-analysis. European Journal of Integrative Medicine. 32. 101005–101005. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026